Nov 14, 2013
Flint, Mich. –Nov. 14, 2013 --- Diplomat, the country’s largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA™ (ibrutinib) capsules, approved Nov. 13 by the U.S.